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Abstract
Background: It is known that making people change their habits is challenging. It is crucial to identify the most
effective approach that general practitioners (GPs) should use to help their patients change unhealthy habits. The
objective this study was to assess the efficacy of a multifactorial intervention based on Motivational Interviewing
performed by general practitioners to enhance lipid levels in patients with dyslipidemia, as compared to standard care.
Methods: A multicenter, controlled, randomized, cluster, two-parallel arm trial with a 12-month follow-up conducted
in 25 community health centers of the Spanish. 38 GPs and 227 primary care patients with uncontrolled dyslipidemia
were included in the trial. GPs performed an intervention based either on Motivational Interviewing (MI) or standard
practice. Lipid levels were measured, and the control degree was analyzed based on the criteria of clinical guidelines.
Results: 107 were assigned to the Experimental Group (EG) and 120 to the Control Group (CG). An overall improvement
was achieved in total cholesterol levels (Mean Difference –MD- = −19.60; 95 % CI: −15.33 at −23.87 mg/dl; p < 0.001),
LDL-cholesterol levels (MD = −13.78; 95 % CI: −9.77 at −17.79 mg/dl; p < 0.001) and triglycerides (MD = −19.14; CI 95 %:
−11.29 at −26.99 mg/dl; p < 0.001). No differences were found between the two groups. However, when we assessed
the degree of lipid control by combining cholesterol <200 mg/dl and LDL-cholesterol < 130 mg/dl parameters, it was
observed that a higher percentage of patients achieved target figures in the EG versus CG (13.1 % vs. 5.0 %; adjusted
OR = 5.77, 95 % CI: 1.67-19.91).
Conclusion: A Motivational Interviewing-based approach conducted by Primary Care physicians aimed at patients
with dyslipidemia, achieved a significant reduction in all lipid parameters, cardiovascular risk, weight reduction and the
adherence to the Mediterranean diet, similar to that obtained with the usual intervention and superior in the proportion
of patients achieving combined lipid control goals and the level of physical exercise.
Trial registration: the trial is registered in ClinicalTrials.gov (NCT01282190; January 21, 2011).
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factors
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Background
Cardiovascular diseases (CVD) are a major cause of
death in developed countries [1]. CVD have a multifac-
torial origin, and dyslipidemia is one of the main risk
factors for this type of disease. CVD prevention strat-
egies are usually based on the identification and manage-
ment of cardiovascular risk factors, many of which are
related with lifestyle and habits. Making lifestyle changes
by adopting healthy habits such as eating healthy foods
and increasing physical activity are essential to the con-
trol of dyslipidemia and the prevention of CVD. In this
sense, the European Guidelines on Cardiovascular Disease
Prevention in Clinical Practice [2] highlight the role of
GPs, who are considered key to initiating, coordinating
and providing long-term follow-up for the prevention of
CVD. GPs have an essential role in the identification of
patients at risk for CVD.
It is known, however, that making people change their
habits is challenging. It is crucial to identify the most
effective approach that GPs should use to help their
patients change unhealthy habits.
Motivational Interviewing, as defined [3] is a clinical
approach aimed at increasing patients' inherent motiv-
ation for change by helping them explore and solve their
ambivalences and resistance to change from a patient-
centered approach. In the authors' words, "MI is a col-
laborative goal-oriented method of communication with
particular attention to the language of change" [4]. It
involves the conscious and disciplined use of specific
communication principles and strategies based on the
concept that clinical communication is a set of behaviors
that can be adopted, observed and measured as any
other clinical skills.
MI has been shown to be effective in a variety of con-
texts in helping patients change unhealthy habits [5–8].
However, more robust evidence is needed on its effect-
iveness in approaching health problems such as dyslipid-
emia in the primary care setting, since only a few studies
are focused on changing this cardiovascular risk factor.
It is noticeable the study by Mhurchú et al. [9] that
included 121 patients with hyperlipidemia recruited in
community health centers and referred to a hospital
dietetic department, who were randomized to receive
either standard or motivational dietary interventions
designed by a dietitian. At three month follow-up, both
groups had improved their dietary habits significantly
and body mass indices, although lipid levels did not
change. Other studies not specifically focused on pa-
tients with dyslipidemia did assess changes in blood lipid
levels as a secondary outcome in an intervention aimed
at modifying other cardiovascular risk factors [10–14].
However, only a few studies have been performed in a
real clinical practice setting where MI was incorporated
as a part of standard primary care.
All this said, we decided to perform a study to assess
the effectiveness of using MI during patients' visits to
the GP versus the standard communicational approach
in favoring cardioprotective behaviors (heart protective
diet, physical activity, weight loss) and improving the
control of lipid levels, thus reducing cardiovascular risk.
Methods
The protocol of this study has been published previ-
ously [15] (See Additional file 1).
Study design
We carried out a multicenter, open, controlled, ran-
domized, cluster, two-parallel arm trial (Experimental
Group -EG- and Control Group -CG-) with a 12-
month follow-up conducted in community health cen-
ters of the Spanish National Health System.
Setting and participants
This trial was conducted using the cluster design, where
two subpopulation levels were considered: [1] health
professionals and [2] patients.
Health professionals
General practitioners at community health centers were
recruited by convenience sampling. Inclusion criteria
were: commitment to stay at their job at least one year,
and signing an Confidentiality Agreement. GPs with pre-
vious training in MI were excluded.
A total of 54 GPs from 32 community health centers
were finally included after excluding those who did not
meet inclusion criteria or lost interest in the project.
Patients were recruited by the participating GPs
Inclusion criteria were being aged 40 to 75 years,
having a de novo diagnosis of dyslipidemia based on
the following simplified classification [16]: a) Defined
hypercholesterolemia: total cholesterol >250 mg/dl
and triglycerides <200 mg/dl; b) Hypertriglyceridemia:
total cholesterol <200 mg/dl and triglycerides >200 mg/dl;
or c) Mixed hyperlipidemia: total cholesterol >200 mg/dl
and triglycerides >200 mg/dl.
Exclusion criteria were: Patients with conditions that
may cause secondary dyslipidemia and need pharmaco-
logical therapy for their condition; patients with previous
cardiovascular events or other chronic conditions as
diabetes or severe chronic obstructive pulmonary dis-
ease, cancer, serious liver failure, chronic renal failure,
alcohol or other substance abusers; patients who, be-
cause of their personal or labor characteristics, were
unable to comply with the study procedures or to be
subject to follow-up review; pregnant or nursing women;
and patients prescribed hypolipidemic pharmacological
treatment.
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Intervention
Intervention with health professionals
Intervention common to both groups Before initiating
patient recruitment, the participating health professionals
attended a workshop on how to approach patients with
dyslipidemia following a protocol specially designed for
this trial and current clinical practice guidelines [17]. They
also received training in consultation videotapes.
Finally, all participants were interviewed to assess their
knowledge of patient interview and examine whether the
groups were well-balanced.
In order to assess the GPs's baseline skills, before initi-
ating the intervention with the patients physicians were
video recorded as they consulted with two standardized
patients with dyslipidemia trained in simulating office
visits. Upon completion of the field work, physicians
were video recorded again with two clinical cases similar
to those seen at baseline and with the same actors. As a
quality control measure and to assess physicians' adher-
ence to the protocol, we recorded four real interviews
between each participating physician and one of the pa-
tients recruited. All video recordings were scored using a
Motivational Interviewing Assessment Scale (EVEM) [18].
Our research group previously demonstrated EVEM's
reliability in assessing psychometric properties (intraclass
correlation coefficient: >0.96; Cronbach's alpha: >0.95); as
well as its validity and sensitivity to change. Change was
assessed by determining differences in the scores obtained
by the patients on the EVEM scale before and after the
intervention. No differences were observed between the
two groups at baseline, while differences were found -the
higher the score, the more extensive the use of MI- both,
after the training course for GPs (pre-training score =
23.63 vs. posttraining = 38.57; t = −4.549; p < 0.001), and in
the evolution from the initial and the final visit (22.51 vs.
24.96, respectively; F = 3.039; p = 0.023-).
Intervention in the Experimental Group Our research
group designed a specific training program for the GPs
included, which consisted of two parts: 1) A 16-hour
training course delivered by an expert and focused on
the eight basic MI tasks [19]. 2) After completion of the
training program, two visits were recorded in which
standardized patients simulated a situation similar to
that of the visits previously recorded. Then, physicians
attended an individual feedback session with an expert
in MI. 3) Initial training was reinforced and maintained
during field work through the following actions: a) each
participant received "educational micropills" regularly via
Internet and SMS messages; b) each participant was
assigned a task and received feedback later; c) each par-
ticipant attended group sessions to analyze their own
visits with real patients using Problem Based Interview-
ing method [20].
Intervention in the control group This group received
no training in patient interviewing. The participants of
this group were given strict instructions that his interven-
tion should be the one normally developed in consultation
with these patients.
Intervention with patients
Once physicians had been trained, the field work was
initiated.
Patient recruitment Patients were recruited by their
general practitioner, who evaluated them in an initial
visit to determine whether they met inclusion or exclu-
sion criteria. The recruitment period was 18 months.
Written consent was obtained from all patients.
Intervention with patients The patients in the CG re-
ceived standard care that consisted of providing advice on
the necessity of changing unhealthy habits towards cardio-
protective habits, according to clinical protocol recom-
mendations. A MI-based approach was used in patients
in the EG in combination with clinical protocol rec-
ommendations. Both interventions were performed by
the patients' usual GPs and were integrated into stand-
ard primary care. The follow-up period was 12 months,
with visits at baseline and at 2, 4, 8 and 12 months.
Sample size
Basing on the results reported in previous studies [9, 21],
assuming a 40 mg/dl variance in cholesterol levels, a SD =
15 mg/dl for total cholesterol, for an alpha error = 0.05
and a beta error = 15 %, 256 patients had to be recruited.
As this was a randomized cluster study, the "design
effect" was taken into account during sample size calcu-
lations. Intra-cluster correlation coefficients (ICC) in
cluster primary care trials are generally lower than 0.05
[22]. For a cluster size of 15, the ICC translated into a
design effect of 1.7. Considering this value, the number
of subjects to be recruited would be 218 for each group,
whereas the number of GPs would be 48 to 50.
Although at the beginning a total of 91 GPs showed
interest in participating in the trial, only 54 were finally
included, since the other GPs did not meet the inclusion
criteria or lost interest in the project. Thus, centered,
blind, simple randomization was performed at a 1:1 ra-
tio. For different reasons -either personal or profes-
sional-, 16 of the GPs included in the study left the trial
before initiating patient recruitment. Therefore, the final
number of GPs included in the study was 38, whereas
the final number of patients recruited was 227. GPs
recruited patients by consecutive sampling during their
visits for whatever reason.
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Outcome measures
Variables collected during the visits were: age, sex, marital
status, education level, social class, family status, family
history of premature cardiovascular disease, comorbidity,
current drugs consumption, snuff consumption (smoker,
ex-smoker, non-smoker, number of cigarettes/day in case
of smokers), and alcohol intake (basic units of alcohol/
week), anthropometric data (weight, height, body mass
index, waist circumference, blood pressure, heart rate),
analytical data (total cholesterol, LDL-cholesterol, HDL-
cholesterol, triglycerides, glucose, creatinine, uric acid,
GOT/GPT/GGT, glomerular filtration rate), abnormal
ECG, cardiovascular risk (SCORE, Framingham) [23, 24],
diet (diet questionnaire Mediterranean) [25], physical ac-
tivity (IPAQ questionnaire) [26], and adherence to medica-
tions (Haynes-Sackett and Morisky-Green tests) [27, 28].
Measurement instruments
Data were recorded in two data collection logs (DCL),
one for each group. In addition, GPs used a procedure
manual including a clinical protocol for approaching
patients with dyslipidemia [16].
Coding procedure
Our research group revised the DCL and watched the
video recordings to verify that data had been properly
entered. When an error in data entry was detected, the
study supervisor asked the corresponding researcher to
correct the errors or deficiencies found.
Statistical analysis
The statistical analysis included the following elements:
1. Descriptive analysis.
2. Baseline analysis: We compared sociodemographic
and clinical characteristics of the EG with those of
the CG.
3. Analysis of the effectiveness of the intervention: We
also performed an intention-to-treat analysis including
all the patients that received at least the first
intervention.
The criteria used to consider good lipid control have
been adjusted to the recommendations of clinical prac-
tice guidelines that were current at the time of the study
design [16, 17] (total cholesterol <200 mg/dl and LDL-
cholesterol <130 mg/dl or total cholesterol <200 mg/dl,
LDL-cholesterol <130 mg/dl and triglycerides <200 mg/dl).
Finally, we assessed differences in primary and second-
ary outcomes between the two groups and among
follow-up visits. Student's t-test was used for comparison
of means of independent samples, whereas ANOVA,
Chi-squared test or Fisher's exact or McNemar test were
employed for repeated measures. When the outcomes
did not follow a normal distribution (Shapiro-Wilk test),
non-parametric tests were used, such as the Mann-
Withney U test, Friedman test, or Kruskal–Wallis test
(p ≤ 0.05). Multivariate statistics (Multiple Linear Regres-
sion or Unconditional Logistic Regression or Multilevel
Logistic Regression, considering the doctor as a first
level of analysis and the patient as a second level) is also
applied. The independent variables considered in every
model were sociodemographic, those clinical or epidemio-
logical relevant, and the variable "intervention group"
(Experimental vs. Control). For modeling we use the
“Enter” method on SPSS. The qualitative variables were
treated as categorical dummy variables. The goodness of
fit of the logistic regression model was checked with the
Hosmer-Lemeshow.
The study was approved by the Ethics Committee for
Clinical Research of the Hospital Universitario Reina
Sof ía (Córdoba) and Ethics Committee for Clinical Re-
search of Galicia.
Results
Description of the population sample and between-group
baseline comparability
The study included 227 patients who were recruited by
38 physicians from 25 community health centers in
Spain. Eighteen physicians were assigned to the EG and
20 to the CG. The evolution and number of dropouts
are detailed in the flowchart, following CONSORT Group
recommendations (Fig. 1) [29]. Of the 227 patients in-
cluded 107 were assigned to the EG and 120 to the CG.
The mean number of recruited patients was 5.9 per GP
for the EG (range: 1–10) and 6 for the CG (range: 2–10).
A total of 196 patients −98 in each group- completed the
follow-up period (lost-to follow up rate: 13.6 %).
Both groups were similar as to baseline characteristics
(Tables 1 and 2). As shown on the flowchart, more women
(62.1 %) than men were recruited to both groups; the aver-
age age was 53.7 years. As to marital status, a higher pro-
portion of widowers and widows was observed in the EG.
Results by outcome
Lipid parameters (Figs. 2, 3 and 4)
The mean level of cholesterol dropped significantly in
the two groups during the follow-up period (mean
difference -MD- = −19.60; 95 % 95 % CI: −15.33 to
−23.87 mg/dl; Friedman test = 91.756; p < 0.001), with no
differences between the two groups (F = 0.021; p = 0.996).
Multivariate analysis showed that the predictors of total
cholesterol levels as measured at the end of the study were
(F = 4.765; p < 0.001; R2 = 0.464): the participating phys-
ician (p = 0.050), adherence to Mediterranean Diet (p <
0.001), baseline cholesterol level (p < 0.001) and use of
statins (p < 0.001).
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Similarly, a significant reduction in mean LDL-
cholesterol levels was achieved in the total sample (MD=
−13.78; 95 % CI: −9.77 to −17.79 mg/dl; Friedman test =
58.856; p < 0.001), with no significant differences between
the groups (F = 0.067; p = 0.977). Predictors of LDL-
cholesterol levels at the end of the study were (F = 2.643;
p = 0.001; R2 = 0.392): Mediterranean Diet (p = 0.011),
baseline LDL-cholesterol level (p < 0.001) and use of sta-
tins (p = 0.004).
The mean triglyceride level was reduced significantly
in both groups (MD = −19.14; 95 % CI: −11.29 to
−26.99 mg/dl; Friedman test = 23.390; p < 0.001), with no
differences between the two groups (F = 0.216; p = 0.886).
The multivariate model (F = 2.643; p = 0.001; R2 = 0.596)
showed that the only predictor of triglyceride levels mea-
sured at the end of the study was baseline triglyceride
levels (p < 0.001).
Conversely, no significant differences were observed in
HDL-cholesterol levels after the intervention when
assessed globally (MD = 0.28; 95 % CI: −2.26 to 1.69 mg/
dl; Friedman test = 3.591; p = 0.309). As it occurred with
the other lipid parameters, no significant differences
Fig. 1 Flowchart of participants according to the CONSORT Group recommendations
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Table 1 Sociodemographic characteristics and lifestyle of patients by baseline group (SD: Standard Deviation; HBP: High Blood
Pressure; SDU: Standard Drinking Units; IPAQ: International Physical Activity Questionnaire)
VARIABLES Experimental group n = 107 Control group n = 120 P value
AGE: Mean ± SD 52.83 ± 8.59 54.84 ± 8.53 0.079
SEX: n° (%)
Women 63 (58.9) 78 (65.0) 0.343
Men 44 (41.1) 42 (35.0)
MARITAL STATUS: No. (%)
Single 3 (2.8) 8 (6.7) 0.015
Married/has a partner 91 (85.0) 92 (76.7)
Separated 11 (10.3) 7 (5.8)
Widowed 2 (1.9) 13 (10.8)
EDUCATIONAL LEVEL: No. (%)
No Education 9 (8.4) 12 (10.0) 0.523
Elementary Education 55 (51.4) 70 (58.3)
Secondary Education 28 (26.2) 22 (18.3)
Higher Education 15 (14.0) 16 (13.3)
SOCIAL CLASS: No. (%)
Class I (the highest) 9 (8.4) 10 (8.3) 0.230
II 6 (5.6) 4 (3.3)
III 22 (20.6) 15 (12.5)
IV 36 (33.6) 37 (30.8)
V (the lowest) 34 (31.8) 54 (45.0)
COMORBIDITY
Arterial hipertension: No. (%) 25 (23.4) 30 (25.0) 0.774
Anxiety/Depression: No. (%) 28 (26.2) 33 (27.5)
UNHEALTHY HABITS
SMOKING: No. (%)
Smoker 36 (33.6) 27 (22.5) 0.072
Former smoker 26 (24.3) 25 (20.8)
Non-Smoker 45 (42.1) 68 (56.7)
Years smoking (Mean ± SD) 26.94 ± 11.12 28.04 ± 12.20 0.727
ALCOHOL: No. (%)
Non-drinker 59 (55.1) 75 (62.5) 0.385
Drinker 48 (44.9) 45 (37.5)
SDU/week for smokers (Mean ± SD) 12.51 ± 12.55 8.11 ± 6.04 0.173
USE OF PHARMACOLOGICAL DRUGS: Mean ± SD
Medicine 1.93 ± 1.94 2.55 ± 3.43 0.134
Number of pills/day 2.85 ± 2.16 3.51 ± 4.32 0.298
MEDITERRANEAN DIET:
Questionnaire Score (Mean ± SD) 8.28 ± 2.23 8.32 ± 2.62 0.868
PHYSICAL ACTIVITY
IPAQ: No. (%)
Low or inactive 24 (22.4) 30 (25.0) 0.986
Moderate 44 (41.1) 52 (43.3)
Intense 26 (24.3) 31 (25.8)
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were found in HDL-cholesterol levels between the
groups (F = 0.048; p = 0.826).
When calculating the control degree by groups ac-
cording to the therapeutic objectives achieved at the end
of the study with the LDL-cholesterol < 130 mg/dl criter-
ion, no statistically significant differences were noted.
On the other hand, when we analyzed the combined
cholesterol < 200 mg/dl and LDL-cholesterol < 130 mg/
dl (Fig. 5) lipid parameters, a higher percentage of pa-
tients reached target figures in the EG against CG (13
1 %. vs. 5 %; Chi-square = 4.601; p = 0.028). Moreover,
when we introduced the triglyceride parameter, i.e. chol-
esterol < 200 mg/dl, LDL-cholesterol < 130 mg/dl and
triglycerides < 200 mg/dl, differences were seen also for
EG (8.4 % vs. 3.3 %), even if they were of little signifi-
cance (Chi-square = 2.744; p = 0.087). Table 3 shows the
multivariate analysis which shows that the predictors of
the control degree based on the combined cholesterol <
200 mg/dl and LDL-cholesterol < 130 mg/dl endpoint
were the group (OR = 5.77), the physician (OR = 1.07)
Table 1 Sociodemographic characteristics and lifestyle of patients by baseline group (SD: Standard Deviation; HBP: High Blood
Pressure; SDU: Standard Drinking Units; IPAQ: International Physical Activity Questionnaire) (Continued)
Professional evaluation: No. (%)
Sedentary 42 (41.2) 43 (36.4) 0.399
Active 60 (58.8) 75 (63.6)
Table 2 Patients' clinical and analytical data by baseline group (BP: Blood pressure, Heart Rate (bpm); BMI Body Mass Index,
Adominal circumference (cm); AST: Aspartate Aminotransferase; ALT: alanine aminotransferase; GGT: Gamma Glutamyl
Transpeptidase CKD-EPI: Chronic Kidney Disease Epidemiology Collaboration)
VARIABLES Experimental group n = 107 Control group n = 120 P value
Systolic BP (mmHg): Mean ± SD 129.26 ± 14.54 130.17 ± 15.67 0.595
Diastolic BP (mmHg): Mean ± SD 79.04 ± 9.11 77.90 ± 9.49 0.228
Heart rate (bpm) (mmHg): Mean ± SD 74.08 ± 10.06 74.18 ± 9.59 0.927
BMI: Mean ± SD 28.47 ± 3.90 28.41 ± 4.47 0.670
Waist Circumference (cm): Mean ± SD 94.47 ± 12.00 95.15 ± 11.51 0.744
Family history of early CVD: n (%) 24 (22.4) 16 (13.3) 0.073
ECG: n (%) 0.466
Normal 95 (88.8) 105 (87.5)
Alterations 7 (6.5) 5 (4.2)
Unknown 5 (4.7) 10 (8.3)
ANALYTICAL DATA: Mean ± SD
Total Cholesterol (mg/dl) 263.44 ± 28.26 259.26 ± 26.09 0.098
LDL Cholesterol (mg/dl) 171.89 ± 27.28 171.10 ± 28.56 0.734
HDL Cholesterol (mg/dl) 57.03 ± 17.63 55.55 ± 14.53 0.508
Triglycerides (mg/dl) 170.64 ± 87.93 170.30 ± 106.05 0.516
Creatinine (mg/dl) 0.83 ± 0.17 0.79 ± 0.19 0.039
Glucose (mg/dl) 95.65 ± 10.68 95.76 ± 17.19 0.463
Uric Acid (mg/dl) 4.86 ± 1.52 4.90 ± 1.56 0.883
GOT (UI/l) 22.60 ± 7.96 24.26 ± 11.67 0.658
GPT (UI/l) 25.65 ± 12.0 26.29 ± 16.90 0.693
GGT (UI/l) 38.16 ± 35.47 36.14 ± 29.71 0.966
CKD-EPI (ml/min/1.73 m2) 91.06 ± 12.92 92.98 ± 15.06 0.135
VASCULAR RISK: Mean ± SD
SCORE (%) 1.32 ± 1.50 1.54 ± 1.72 0.346
REGICOR (%) 4.48 ± 2.61 4.47 ± 2.50 0.693
FRAMINGHAM (%) 9.52 ± 6.05 9.98 ± 6.37 0.447
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and the use of statins (OR = 7.19). The multivariate ana-
lysis on Table 4 shows that the predictors of the control
degree based on the combined cholesterol < 200 mg/dl,
LDL-cholesterol < 130 mg/dl and triglycerides < 200 mg/dl
endpoint were the group (OR = 8.41), use of statins
(OR = 20.70) and the Mediterranean diet score at the
final visit (OR = 1.63).
Other outcomes measured
As many as 80.4 % of the patients assigned to the EG
and 79.2 % of patients in the CG had overweight or
obesity. The proportion of obese patients was lowered
by 8.4 % in the EG vs. 6.7 % in the CG, which means a
1.7 % difference between both groups (the reduction
was more prominent in the EG) (McNemar = 13.899;
Fig. 2 Evolution of mean total cholesterol levels throughout the study by group (mg/dl)
Fig. 3 Evolution of mean LDL- cholesterol levels throughout the study by group (mg/dl)
Bóveda-Fontán et al. BMC Family Practice  (2015) 16:151 Page 8 of 16
p = 0.001). When considering only patients with over-
weight or obesity, we found that the mean weight
dropped from 78.76 ± 11.27 kg at baseline to 76.92 ±
12.13 kg at the end of the study (MD = −1.77 kg;
95 % 95 % CI: −0.91 to −2.64 kg; Friedman = 47.599;
p < 0.001). However, differences between the two
groups were not significant (F = 1.258; p = 0.285). A
reduction in body mass index (BMI) from 29.79 ±
3.53 kg/m2 to 29.17 ± 3.54 kg/m2 was also observed
in these patients. Although this reduction is not sta-
tistically significant when the two groups are compared
(F = 0.567; p = 0.452), if we consider the total sample such
difference becomes significant (MD = −0.61 kg/m2; 95 %
CI: −0.34 to −0.88 kg/m2; Friedman = 59.050; p < 0.001).
The MD in the EG was also significant = −0.43 kg/m2;
95 % CI: −0.08 to −0.79 kg/m2).
As to waist circumference, we observed a significant re-
duction in the total sample (MD= −0.100 to −1.607 cm;
Friedman = 47.086; p < 0.001), with no differences between
groups (F = 0.927; p = 0.449). A significant reduction in
waist circumference was observed in the total sample of
patients with obesity or overweight (MD = −079 cm; 95 %
CI: −0.287 to −1.746 cm; Friedman test = 34.272; p <
0.001), from 98.20 ± 9.67 cm to 97.47 ± 8.90 cm at the end
of the study, with no significant differences between
groups (F = 0.545; p = 0.703).
The level of physical activity was measured using
the International Physical Activity Questionnaire (IPAQ
Questionnaire) which showed an increase of physical
activity in both groups (p = 0.030), although it was sig-
nificantly more prominent in the EG (Chi-squared =
23.3; p < 0.01). As many as 96.6 % of patients in the
EG reported a moderate to high level of physical ac-
tivity at the end of the study.
The questionnaire on adherence to the Mediterranean
diet yielded a mean score of 8.30 ± 2.43 at baseline, and
a final score of 9.41 ± 2.47 (MD = 1.11; 95 % CI: 1.42-
7.29; Friedman test = 44.366; p < 0.001) after a one-year
follow-up period. In the final visit, a positive change was
observed in the two groups, with no significant differ-
ences between them (95 % CI of MD: −0.626 to 0.582).
The average points obtained on the SCORE risk charts
dropped significantly for the total sample (MD= −0.17 %;
95 % CI: −0.07 to −0.27; Friedman test = 20.596; p <
0.001), and Framingham (MD: −1.22 %; 95 % CI: −0.81
Fig. 4 Evolution of mean total triglyceride levels throughout the study by group (mg/dl)
Fig. 5 Patients with lipid control in the final visit depending on
the group
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to −1.63; Friedman test = 34.794; p < 0.001), with no
statistically significant differences between the EG and
the CG.
The analysis of consumption of snuff reflects a significant
reduction in the number of smokers from the first to the
last visit in the total sample: 37.0 % reduction in the CG
(McNemar; p < 0.001) and 33.0 % in EG (McNemar; p =
0.012), with no differences between groups. A significant
decrease in average number of cigarettes/day in smokers
(95 % CI = −3.32 to −7.94; mean difference = −5.66;
Friedman test = 46.732; p < 0.001) was evident, without sig-
nificant differences between groups (F = 0.103; p = 0.749).
The average alcohol consumption at baseline, among
subjects who reported drinking it regularly was 8.11 ± 6.04
U/week in CG and 12.51 ± 12.55 U/week at GE. At the
final visit the average consumption dropped to 7.89 ± 7.46
in the CG and 10.62 ± 9.84 in the GE, the global average
decline was 8.92 U/week (95 % CI: −6.84 to −11.01; t =
8.502; p < 0.001). Only 7 of the 227 patients reported
consuming alcohol risk at baseline (6 at the GE and 1 in
the GC). Of these, only three remained hazardous drink-
ing at the final visit (2 in the GE and 1 in the GC).
No significant changes were observed in blood glucose
levels or other biochemical parameters analyzed.
Finally, a higher proportion of patients in the CG were
prescribed statins at the end of the study (19.2 %) as com-
pared to patients in the EG (9.3 %); − Chi-squared = 5.042;
p = 0.025-. Therapeutic adherence to the end of the follow-
up period was 88.5 %, with no significant differences be-




We observed a global improvement in the lipid parame-
ters analyzed, except for HDL-cholesterol. Reductions
were significant both in the patients who received stand-
ard care and in the patients who received the motiv-
ational interviewing-based intervention. No statistically
significant differences were observed.
However, when we analyzed the percentage of patients
who had achieved target figures at the end of the study,
we observed a significantly higher proportion of patients
treated in the GE, both when considering the combin-
ation of cholesterol < 200 mg/dl and LDL-cholesterol <
130 mg/dl, and the combination of cholesterol < 200 mg/dl,
LDL-cholesterol < 130 mg/dl and triglycerides < 200 mg/dl
as well, and adjusting these response variables with other
presumed predictors in a multivariate analysis. This dispar-
ity or alleged discrepancy as to the outcomes can be ex-
plained from a statistical point of view, because when data
are treated as quantitative variables, the used comparison
parameter has been the arithmetic mean and other descrip-
tive measures have been ignored, such as the bias or asym-
metry of the distributions, whereas when the used end-
point is qualitative, and also in combination (i.e. using as
criteria some specific cut points to qualify patients as con-
trolled or not controlled), differences come to the fore
which were not appreciated as quantitative measures.
It is to be noticed that total cholesterol levels were
dramatically reduced and maintained for a year.
No significant correlations were observed between
changes in lipid parameters and independent variables such
as sociodemographic or unhealthy habits of the patient.
No associations were found either between self-reported
level of physical activity in the final visit and changes in
lipid parameters, despite the increase in physical activity.
An association was found between the use of statins and
a higher score on the Mediterranean Diet questionnaire
and total cholesterol and LDL-cholesterol levels. However,
Table 3 Multivariate analysis (multiple logistic regression) with
independent variables considered taking lipid control level
based on the total <200 mg/dl and c-LDL < 130 mg/dl colesterol
(n = 227; OR = Odss Ratio; 95 % CI: 95 % Confidence Interval;
Omnibus test = 35.063; p = 0.038; Hosmer-Lemeshow test = 8.312;
p = 0.319)
Independent variables p OR 95 % CI OR
Lower Upper
Group (Experimental/Control) 0.005 5.77 1.67 19.91
Doctor 0.034 1.07 1.00 1.13
Age 0.252 0.95 0.88 1.03
Sex (Male vs Female) 0.587 1.46 0.36 5.87
Instruction level 0.731
Instruction level (Uneducated vs Higher) 0.998 0.00 0.00
Instruction level (Primary vs Higher) 0.887 1.19 0.09 14.72
Instruction level (Secondary vs Higher) 0.554 0.47 0.04 5.55
Profession (social class) 0.893
Social class I vs V 0.574 0.40 0.01 9.34
Social class II vs V 0.806 0.66 0.02 18.09
Social class III vs V 0.916 0.90 0.13 6.04
Social class IV vs V 0.377 0.49 0.10 2.34
Family Situation (live vs accompanied only) 0.857 0.86 0.16 4.40
Anxiety/Depression 0.801 1.19 0.29 4.80
Smoking final visit 0.456 0.56 0.12 2.52
Alcohol consumption final visit 0.346 0.54 0.15 1.94
Delivery of written information 0.989 1.00 0.29 3.44
BMI final 0.221 1.08 0.95 1.23
Mediterranean diet final visit 0.312 1.15 0.87 1.53
Changes in diet at the end 0.834 1.15 0.31 4.27
Changes exercise final visit 0.066 0.27 0.06 1.08
IPAQ medium/high final visit 0.658 0.70 0.15 3.26
Statins use 0.004 7.19 1.85 27.93
Constant 0.425
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no association was found between the use of statins and
triglyceride levels.
We observed a positive correlation among the three
parameters at baseline and at the end of the study.
A correlation was also found between the participating
physician and total cholesterol levels -regardless of the
type of intervention-, which led us think that other
behavior al factors and professional skills may have an
impact on the outcomes.
Interpretation of findings and comparison with existing
literature
The changes observed in serum cholesterol levels were
more prominent than those reported in previous studies.
In a review on the effectiveness of individual interven-
tions in primary care settings aimed at changing life
habits to reduce cardiovascular risk reported a mean
reduction of 12.76 mg/dl in total cholesterol levels [30].
It is to be noticed that this review included trials that
involved a pharmacological intervention, provided that it
was not the primary outcome. The same author con-
sidered that reductions of 19.3 mg/dl were clinically
relevant.
According to Gotto & Pownall [31], a 10 % reduction
in total cholesterol leads to a mean 8 % reduction in all
causes of mortality. Other data indicates that a slight
reduction (3 %) of total cholesterol results in a 15 %
reduction of cardiovascular events [32]. Conversely a
40 mg/dl reduction of LDL-cholesterol levels is associ-
ated with a 22 % reduction of cardiovascular morbidity
and mortality [33].
Considering these data and taking into account that the
study population had no previous history of cardiovascular
events, we consider that the changes achieved in our study
are clinically very relevant as to their potential for redu-
cing the incidence of cardiovascular disease. In addition,
Table 4 Multivariate analysis (multiple logistic regression) with independent variables considered taking lipid control levels
(cholesterol <200 mg/dl, c-LDL < 130 mg/dl and triglycerides <200 mg/dl) as the dependent variable (OR = Odds Ratio; 95 % CI = 95 %
confidence interval; Omnibus test = 38.597; p = 0.016; Hosmer-Lemeshow test = 8.262; p = 0.408)
p OR 95 % CI OR
Independent variables Lower Upper
Group (Experimental/Control) 0.020 8.41 1.40 50.459
Doctor 0.302 1.04 0.96 1.137
Age 0.145 0.91 0.82 1.030
Sex (Male vs Female) 0.172 3.91 0.55 27.760
Instruction level 0.737
Instruction level (Uneducated vs Higher) 0.998 0.00 0.00 .
Instruction level (Primary vs Higher) 0.268 11.82 0.15 933.239
Instruction level (Secondary vs Higher) 0.362 7.58 0.09 589.011
Profession (social class) 0.799
Social class I vs V 0.469 5.85 0.04 701.661
Social class II vs V 0.341 9.92 0.08 1122.703
Social class III vs V 0.689 0.59 0.04 7.812
Social class IV vs V 0.687 0.64 0.07 5.393
Family Situation (live vs accompanied only) 0.720 0.56 0.02 12.659
Anxiety/Depression 0.661 0.67 0.11 3.946
Smoking final visit 0.772 0.74 0.09 5.666
Alcohol consumption final visit 0.060 0.16 0.02 1.076
Delivery of written information 0.882 1.13 0.22 5.694
BMI final 0.680 1.04 0.86 1.250
Mediterranean diet final visit 0.028 1.63 1.05 2.550
Changes in diet at the end 0.429 0.46 0.07 3.098
Changes exercise final visit 0.210 0.29 0.04 1.994
IPAQ medium/high final visit 0.501 2.56 0.16 39.708
Statins use 0.001 20.70 3.40 125.838
Constant 0.408
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cholesterol levels at baseline were only slightly high, which
made it more difficult to achieve significant variations.
The physicians in the CG prescribed statins for the
treatment of dyslipidemia more frequently than those in
the EG. This means that there was disparity between the
two groups as to the use of pharmacological drugs,
which may be a confounding factor in the interpretation
of the results obtained.
This is noticeable, given that both groups had a similar
health state at baseline. Although similar reductions
were achieved in both groups, more pharmacological
drugs of proven efficacy in reducing lipid levels were
prescribed to the CG.
When pharmacological prescriptions are isolated, a mean
reduction of 17.71 mg/dl in total cholesterol levels is
obtained for the EG vs. 12.53 mg/dl for the CG. Therefore,
the reduction of total cholesterol levels achieved by the GPs
using motivational interviewing (6.72 %) without any
pharmacological treatment were substantially greater as
compared to those obtained in the CG (4.83 %).
Although this difference was not statistically significant,
it is undoubtedly of interest and relevant to the final out-
comes as the multivariate analysis shows. Thus, the multi-
variate analysis confirmed that the use of statins is one of
the main predictors of changes in lipid levels.
This finding suggests that the physicians who used MI
tended to prescribe statins less frequently and only used
them when it was strongly recommended by clinical
guidelines recommendations. This means that the use of
MI may result in a lower use of pharmacological drugs,
which would potentially reduce associated health care
costs and the risk of statin-related side effects.
The existing literature reports that both, dietary inter-
ventions alone and multifactorial interventions reduce
cholesterol levels only slightly (3-5 %) [34].
A Cochrane review [35], was conducted to assess the
effectiveness of dietary advice in improving cardiovascu-
lar risk in healthy adults, reported a mean reduction of
cholesterol levels of 6.19 mg/dl in 3 to 24-month follow-
up periods. According to Cochrane, the outcomes im-
proved when the dietary intervention was performed by
a dietitian rather than by a physician.
However, some studies have demonstrated that pa-
tients could not maintain LDL-cholesterol levels low in
the long term when the intervention was performed by a
dietitian [36].
In our study, the mean weight reduction in patients
with obesity or overweight was 1.78 kg (2.3 % of baseline
weight).
It is essential to maintain weight loss for one year,
since it is the main problem reported by most interven-
tion studies on weight loss [37]. Some authors consider
a ≥1 kg weight loss clinically relevant [30]. Other studies
reporting greater weight losses combined dietary and
exercise interventions with a behavior approach. How-
ever, exercise programs were difficult to comply with [38].
Other studies report significantly greater weight losses
achieved using a motivational intervention. However, the
intensity of the intervention was higher in the motiv-
ational group than in the control group, and weight was
measured only after six months of intervention [39].
A meta-analysis assessing the effectiveness of MI in pa-
tients with overweight or obesity [40] concluded that MI
contributed significantly to weight loss as compared to
controls and highlighted the fact that in several studies
both, the intervention and the control group achieved
significant weight losses. In addition, those studies report-
ing weight loss as the primary endpoint showed better
outcomes than those focused on changing life habits in
general [40].
Dietary habits improved in our study population, with
a mean final score exceeding the threshold indicating
good adherence [25].
It was also noticeable the increase in physical activity
in the EG, which obtained significantly higher scores on
the IPAQ questionnaire than the CG. This is supported
by the high number of patients in the EG reporting to
have moderate to high physical activity in the end of the
study, whereas only a small proportion of patients in this
group (6.3 %) reported that they kept being sedentary.
Although multivariate analysis indicated that there was
no correlation between the high level of physical activity
achieved and the reduction in lipid parameters, it is
undeniable that the increase in physical activity is very
relevant. In fact, there is solid evidence that regular
physical activity is effective in primary and secondary
prevention of different chronic diseases [41]. The relative
risk of developing ischemic heart disease associated with
sedentarism ranges between 1.5 and 2.4 [42].
Also, there is evidence that there is a progressive linear
relation between the level of physical activity and health
status; thus, people who are more active physically are at
a lower risk of developing heart disease [43]. This find-
ing is even more interesting if we consider the moderate
efficacy of the interventions at increasing physical activ-
ity reported in the literature aimed [44].
Other studies performed in the primary care setting
have demonstrated the efficacy of MI-based interventions
in reducing sedentarism. However, these interventions
designed by health professionals are generally more inten-
sive and occasionally include support personnel such as
experts on physical activity, who complement the inter-
vention through personal interviews, phone calls or even
mailed material [10, 11, 45]. Even in more intensive inter-
ventions, improvements have been reported in the long
term for the two groups [46].
The existing literature indicates that lifestyle interven-
tions in primary care aimed at patients at low CVR
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cardiovascular risk are barely effective or, at least, there
is no sufficient evidence on their effectiveness when a
multifactorial approach is used [47, 48]. This is the case
of comprehensive interventions aimed at improving diet-
ary habits, physical activity and weight in patients with
lipid disorders. Some studies report that MI is more
effective in patients at a higher baseline risk of CVD
[49]. The studies using MI in patients with lipid disor-
ders report a variety of outcomes.
Thus, Woollard [14] did not found any significant dif-
ferences in the lipid profile, dietary habits or weight of
patients after an intervention performed by nurses
trained in MI, as compared to standard advice delivered
by GPs to patients with high cardiovascular risk. Woollard
reported a 3 % reduction of total cholesterol in the EG vs.
a 2 % reduction in the CG at 12 months.
Elley [10] and Lawton [11] performed two primary
care interventions aimed at increasing PA in a sedentary
population using a motivational approach. However, they
did not achieve to increase physical activity, weight loss
or reduce blood pressure or lipid levels, which were sec-
ondary outcomes.
We did not find any other trial where GPs highly trained
in MI have implemented an efficient intervention where
biological parameters associated with health habits were
measured for a year. We only found a similar study [50]
that showed that training primary care professionals in
Behavior Change Counseling was not more effective in
achieving changes in life habits or in biochemical or an-
thropometric parameters, as compared to standard care.
Some studies have reported positive effects of MI on
biological parameters. However, these studies have meth-
odological limitations.
Kreman [51] reports a significant reduction of total
and LDL-cholesterol levels in patients with dyslipidemia
using a single motivational intervention through the
telephone. But the sample size was very small and the
study period very short.
There are a large number of publications on MI inter-
ventions performed in primary care; however, they were
not implemented by experts on MI or were integrated
into regular practice. Thus, the study by Hardcastle [49]
in the United Kingdom was performed in a community
health center by experts in PA and dietitians rather than
by GPs.
Another important finding of our study was the differ-
ence found in the overall percentage of dropouts during
the follow-up period. There were more dropouts in the
CG (18.4 %) than in the EG (8.5 %), which means that
adherence was significantly higher in the EG. The higher
adherence in the EG might be due to the effect of
MI, which favors patient's engagement (one of the
four pillars of MI) and the quality of patient-physician
communication.
Strengths and limitations of this study
Although this trial was implemented in experimental
conditions, they were very similar to conditions in regu-
lar primary care. This gives greater external validity to
the study, since conditioning factors such as care over-
load and time constraints were considered.
An intervention based on the patient-doctor relationship
should be assessed at two levels: the acquisition of skills
by health professionals and the intended behavior change
in patients. All authors highlight the importance of con-
sidering aspects such as professionals skills, recruitment
methods and adherence to intervention protocols [52].
Madson & Campbell [53] emphasized the need for
effective objective observation tools for assessing MI re-
liability and quality.
Internal validity was achieved by implementing com-
prehensive control measures during the study, from the
selection of the study design (randomization in groups),
to the use of an educational program for physicians
based on the eight MI skills. In addition, we assessed
participants' adherence to the intervention protocol and
verified its reliability; implementation differences be-
tween the two arms of the study were assessed using a
measure tool previously validated (EVEM) [18].
It is understood that physicians may have considerable
influence on patients' health-related behaviors [54]. On
the other hand, a limitation of this study is the fact that
the physicians who agreed to participate in such a com-
plex trial may have been those who were more skilled
and motivated to improve their communication skills
and patient-centered practice, which would result in
self-selection bias. Thus, the participating physicians
might be more skilled than the average physician [55].
But the main limitation of this study is the rate of par-
ticipation among physicians, which was lower than the
rate initially achieved (38 of the initial 50). This would
lead to the self-selection bias mentioned above and to
randomized errors, since we worked with a statistical
power which was less than desirable (type II error).
The low rate of participation among physicians hin-
dered patient recruitment, which led to a final sample
smaller than expected. This sample size allowed us to
detect statistically significant differences, assuming a
mean total cholesterol level of 235 mg/dl in the EG and
250 mg/dl in the CG, with a standard deviation of
24.0 mg/dl for an alpha risk of 5 % and a beta risk of
5 %, and considering the estimations described in sec-
tion Methods.
A potential source of variation in MI effectiveness is
the nature of the sample treated. The characteristics of
patients may moderate the effectiveness of MI, since
those initiating the treatment who already are ready for
change may benefit less from MI because their ambiva-
lence is already overcome [4].
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Often, patients who decide to participate in a trial already
have the motivation for change before the intervention.
The percentage of drop-outs was higher in the CG than in
the EG. This means that adherence was higher in the EG,
which might lead to differential selection bias and affect the
outcomes, since non-respondents are usually poorly con-
trolled and do not follow recommendations.
On the other hand, this study might be subject to
attentional bias -Hawthorne effect [55]- by which just
the fact of being included in a study -and even before
receiving the intervention- the subject may present be-
havioral changes. This might explain the improvements
also observed in the CG, which in this case might affect
both, professionals and patients. It is difficult to avoid
this bias, since it is inherent to most trials, especially to
experimental trials.
A common concern among primary care professionals
are time constraints on interventions. However, the meta-
analysis by Van Buskirk [56] showed that the total time
devoted to patient-physician communication was not rele-
vant to effect size. In our study we could not assess differ-
ences in the duration of patient-physician interviews due
to the low number of GPs who recorded correctly this
data.
Conclusion
Both MI and Standard Care significantly reduce total
cholesterol, LDL-cholesterol and triglyceride levels after
a one-year follow-up program. The same thing happens
with the reduction of the CVD risk, the adherence to
the Mediterranean diet and the reduction of the corporal
weight.
MI is superior than Standard Care in the proportion
of patients achieving objectives combined lipid control
and manages patients to increase their level of physical
exercise in a greater degree than the usual approach.
Therefore, the EM can have an effect in patients with
dyslipidemia in primary care but it is necessary to con-
tinue with quality studies that corroborate it.
MI is a useful clinical method in primary care that can
be learned and used by health professionals to achieve
changes in lifestyle of patients. The utility of MI in
primary care stems from the possibility of combining it
with other educational (advice, counseling…) and clinical-
pharmacological interventions.
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